Vadodara, India

Vimal Kaneria

This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignee: Sun Pharmaceutical Industries Limited. Active years: 2017-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vimal Kaneria. Retrieved from https://idiyas.com/inventor/vimal-kaneria

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 50.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Bopal, IN (2017 - 2019)
  • Baroda, IN (2018 - 2019)

Company Filing History:


Years Active: 2017-2019

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Vimal Kaneria: Innovator in Pharmaceutical Advancements

Introduction

Vimal Kaneria is a notable inventor based in Baroda, India. He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work focuses on developing innovative solutions for drug delivery and stabilization.

Latest Patents

Among his latest patents, Vimal Kaneria has developed a method for stabilizing linaclotide in a solid dosage form. This invention addresses the challenges associated with the stability of this important medication. Additionally, he has created novel oral sustained release pharmaceutical dosage forms for the delivery of budesonide, specifically targeting the lower gastrointestinal tract for the treatment of Crohn's disease.

Career Highlights

Vimal Kaneria is currently employed at Sun Pharmaceutical Industries Limited, a leading global pharmaceutical company. His role involves research and development, where he applies his expertise to create effective pharmaceutical formulations.

Collaborations

Throughout his career, Vimal has collaborated with esteemed colleagues such as Rajamannar Thennati and Shirish Kulkarni. These partnerships have further enhanced his innovative capabilities and contributed to the success of his projects.

Conclusion

Vimal Kaneria's contributions to pharmaceutical innovations demonstrate his commitment to improving drug delivery systems. His patents reflect a deep understanding of the complexities involved in medication stabilization and release.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…